Training in the Pharmacology of Abused Drugs

滥用药物药理学培训

基本信息

  • 批准号:
    8287561
  • 负责人:
  • 金额:
    $ 57.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1976
  • 资助国家:
    美国
  • 起止时间:
    1976-07-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): We are requesting continued funding of this productive training program to support predoctoral and postdoctoral fellows in the biomedical aspects of drugs of abuse. The training record of this program is outstanding, due to the quality of the trainees and preceptors and its organizational structure. A large number of individuals who received training from these preceptors have progressed to become leaders in the drug abuse field and a very impressive number have earned funding from NIDA and other sources for their substance abuse-related research. Since the submission of our last competitive application we have recruited five faculties from other institutions and many faculties from other departments in this university. Thus we are requesting support for two additional predoctoral and postdoctoral trainees our preceptors provide "cutting edge" expertise in molecular, cellular, behavioral, clinical and translational aspects of this area of research. The major emphasis of this program continues to be concentrated on the pharmacology and mechanism of action of abused drugs and mechanisms of addiction. We continue to have a broad scope in our training program and expect that each preceptor will bring his or her specific expertise to the benefit of all trainees. This is accomplished through the wide variety of courses, the high level of collaboration among the mentors, the faculty serving on thesis committees and our excellent seminar series. The program has enjoyed and will continue to benefit from strong administrative support from the Department of Pharmacology and Toxicology and new up to date laboratories with modern major equipment, including confocal microscopy, mass spectrometry, and facilities for non-human primate behavioral testing. The predoctoral training program is rigorous and is characterized by two years of required course work and participation in excellent research projects. The major emphasis of all training supported by this program is on research. The faculty have earned the research support for the trainees through the significant number of grants they have generated. The research projects of the fellows in this program will continue to be directed toward elucidating the abuse potential, the cellular, molecular and behavioral mechanisms of action and pharmacological properties of drugs of abuse and addiction. Postdoctoral fellows will concentrate on research throughout their training. The faculty will provide guidance on research, teaching and the professionalism of a career in biomedical science and all aspects of becoming a productive and independent researcher. This has been a hallmark of this program and will continue to provide the atmosphere for the training of leading scholars in the drug abuse field for the future.
描述(由申请人提供):我们要求继续为这项生产培训计划提供资金,以支持滥用药物的生物医学方面的专业和博士后研究员。由于受训者和主持人及其组织结构的质量,该计划的培训记录非常出色。从这些受体中接受培训的许多人已经进步,成为吸毒领域的领导者,并且有一个非常令人印象深刻的人从NIDA和其他来源获得了与药物滥用相关的研究的资金。自上次竞争申请提交以来,我们已经招募了来自其他机构的五个学院以及该大学其他部门的许多学院。因此,我们要求支持两个研究领域的其他学员提供两个额外的前和博士后学员,以提供“最前沿”的专业知识。该计划的主要重点继续集中在滥用药物和成瘾机制的药理和作用机理上。我们继续在培训计划中拥有广泛的范围,并期望每个主持人将其特定的专业知识带来所有受训者的利益。这是通过各种各样的课程,导师之间的高水平合作,在论文委员会中任职的教师和我们出色的研讨会系列。该计划享有并将继续从药理学和毒理学系以及具有现代主要设备的新最新实验室中受益,包括共聚焦显微镜,质谱和非人类灵长类动物行为测试的设施。专用培训计划是严格的,其特征是两年必需的课程工作以及参与出色的研究项目。该计划支持的所有培训的主要重点是研究。该学院通过他们产生的大量赠款为学员赢得了研究支持。该计划中的研究员的研究项目将继续致力于阐明滥用行动的细胞,分子和行为机制以及滥用和成瘾药物的药理特性。博士后研究员将集中精力研究整个培训。该学院将提供有关生物医学科学职业的研究,教学和专业精神的指导,以及成为一名富有成效和独立研究人员的各个方面。这一直是该计划的标志,并将继续为未来的药物滥用领域的领先学者培训提供氛围。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William L. Dewey其他文献

Derivatives of Apomorphine and of Other <em>N</em>-Substituted Norapomorphines
  • DOI:
    10.1002/jps.2600651129
  • 发表时间:
    1976-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Edward R. Atkinson;S.P. Battista;Istvan E. Ary;Donald G. Richardson;Louis S. Harris;William L. Dewey
  • 通讯作者:
    William L. Dewey
Excretion of <em>trans</em>-Δ<sup>9</sup>-Tetrahydrocannabinol and Its Metabolites in Intact and Bile Duct-Cannulated Rats
  • DOI:
    10.1002/jps.2600620506
  • 发表时间:
    1973-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Robert F. Turk;Louis S. Harris;William L. Dewey
  • 通讯作者:
    William L. Dewey
Mo1598 - Colonic Supernatants from Chronic Morphine Exposed Mice Induce Morphine Tolerance in Naïve Dorsal Root Ganglion Neurons that is Mitigated by Oral Vancomycin Delivery
  • DOI:
    10.1016/s0016-5085(17)32537-4
  • 发表时间:
    2017-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Ryan Mischel;William L. Dewey;Hamid I. Akbarali
  • 通讯作者:
    Hamid I. Akbarali
Preparation and Activity of <em>β</em>-Substituted Acetylcholine Iodides
  • DOI:
    10.1002/jps.2600601144
  • 发表时间:
    1971-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    George H. Cocolas;Ellen C. Robinson;William L. Dewey;Theodore C. Spaulding
  • 通讯作者:
    Theodore C. Spaulding
Mo1539 - μ-Opioid Receptors Co-Expressed in Cholinergic Neurons of Mouse Ileum Myenteric Plexus Develop Tolerance to Chronic Morphine Exposure
  • DOI:
    10.1016/s0016-5085(17)32478-2
  • 发表时间:
    2017-04-01
  • 期刊:
  • 影响因子:
  • 作者:
    Karan Muchhala;Aravind Gade;William L. Dewey;Hamid I. Akbarali
  • 通讯作者:
    Hamid I. Akbarali

William L. Dewey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William L. Dewey', 18)}}的其他基金

Training in the pharmacology of abused drugs
滥用药物药理学培训
  • 批准号:
    9386216
  • 财政年份:
    2016
  • 资助金额:
    $ 57.96万
  • 项目类别:
The Central Virginia Center on Drug Abuse Research
弗吉尼亚中部药物滥用研究中心
  • 批准号:
    10604263
  • 财政年份:
    2013
  • 资助金额:
    $ 57.96万
  • 项目类别:
The Central Virginia Center on Drug Abuse Research
弗吉尼亚中部药物滥用研究中心
  • 批准号:
    9189703
  • 财政年份:
    2013
  • 资助金额:
    $ 57.96万
  • 项目类别:
The Central Virginia Center on Drug Abuse Research
弗吉尼亚中部药物滥用研究中心
  • 批准号:
    10374821
  • 财政年份:
    2013
  • 资助金额:
    $ 57.96万
  • 项目类别:
The Central Virginia Center on Drug Abuse Research
弗吉尼亚中部药物滥用研究中心
  • 批准号:
    8552155
  • 财政年份:
    2013
  • 资助金额:
    $ 57.96万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10374822
  • 财政年份:
    2013
  • 资助金额:
    $ 57.96万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10604264
  • 财政年份:
    2013
  • 资助金额:
    $ 57.96万
  • 项目类别:
The Role of Protein Kinase C in Opioid Tolerance
蛋白激酶 C 在阿片类药物耐受中的作用
  • 批准号:
    7278267
  • 财政年份:
    2006
  • 资助金额:
    $ 57.96万
  • 项目类别:
The Role of Protein Kinase C in Opioid Tolerance
蛋白激酶 C 在阿片类药物耐受中的作用
  • 批准号:
    7465564
  • 财政年份:
    2006
  • 资助金额:
    $ 57.96万
  • 项目类别:
The Role of Protein Kinase C in Opioid Tolerance
蛋白激酶 C 在阿片类药物耐受性中的作用
  • 批准号:
    7148489
  • 财政年份:
    2006
  • 资助金额:
    $ 57.96万
  • 项目类别:

相似国自然基金

CD40hiCD138hiPIR-Ahi巨噬细胞训练免疫的形成及其促进慢性排斥反应的机制研究
  • 批准号:
    82371794
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
面向底层视觉任务的通用自监督预训练基础模型研究
  • 批准号:
    62371164
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
认知原理启发的训练仿真系统战场空间表示方法研究
  • 批准号:
    62306329
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
支持深度伪造检测的精细化高效训练集生成方法研究
  • 批准号:
    62372423
  • 批准年份:
    2023
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目
面向大规模图预训练模型的知识迁移关键问题研究
  • 批准号:
    62376129
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Impact of Cocaine History on Pharmacotherapy Effectiveness
可卡因史对药物治疗效果的影响
  • 批准号:
    10750162
  • 财政年份:
    2023
  • 资助金额:
    $ 57.96万
  • 项目类别:
Elucidating the role of the endogenous opioid dynorphin in reward seeking
阐明内源性阿片类强啡肽在寻求奖励中的作用
  • 批准号:
    10722734
  • 财政年份:
    2023
  • 资助金额:
    $ 57.96万
  • 项目类别:
Locus coeruleus-norepinephrine regulation of stress-induced anxiety and opioid reinstatement
蓝斑-去甲肾上腺素对应激性焦虑和阿片类药物恢复的调节
  • 批准号:
    10677132
  • 财政年份:
    2023
  • 资助金额:
    $ 57.96万
  • 项目类别:
Molecular target and circuitry underlying the preclinical effects of psychedelics in models of opioid use disorder
阿片类药物使用障碍模型中迷幻药临床前作用的分子靶点和电路
  • 批准号:
    10751173
  • 财政年份:
    2023
  • 资助金额:
    $ 57.96万
  • 项目类别:
The University of Kentucky Racial Equity Initiative Coordinating Center
肯塔基大学种族平等倡议协调中心
  • 批准号:
    10740150
  • 财政年份:
    2023
  • 资助金额:
    $ 57.96万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了